Patients with severe melanoma who received the treatment were 49% less likely to die or have their cancer return, ...

A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a ...

Ibuprofen may be doing more than easing aches and pains—it could also help reduce the risk of some cancers. Studies have ...

A study led by Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D., at MUSC Hollings Cancer Center, reveals why a specific gene ...

A combination of intismeran autogene and Keytruda significantly prolonged recurrence-free survival in melanoma.

Join our free daily Horoscope newsletter!

High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell ...

A vitamin A byproduct could weaken the immune system's cancer-fighting ability, according to new Princeton University ...

Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...

Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...

We’ve reported on the link between eating processed meats and a higher risk of developing cancer. But new research suggests ...

Seven in 10 people now survive five years or more after diagnosis, according to the latest annual report from the American ...